Announcements Trials
Browse Landscape

Status

Recruiting 2Not yet recruiting 2Withdrawn 1Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 302Carcinoma, Non-Small-Cell Lung 237Prostatic Neoplasms 194Neoplasms 186Lung Neoplasms 145Multiple Myeloma 140Neoplasm Metastasis 107Colorectal Neoplasms 104Melanoma 93Ovarian Neoplasms 88Leukemia, Myeloid, Acute 80Pancreatic Neoplasms 77Lymphoma 73Leukemia, Lymphocytic, Chronic, B-Cell 69Brain Neoplasms 67Carcinoma, Renal Cell 66Lymphoma, Non-Hodgkin 64Squamous Cell Carcinoma of Head and Neck 62Carcinoma, Hepatocellular 59Urinary Bladder Neoplasms 58Hematologic Neoplasms 57Recurrence 56Head and Neck Neoplasms 56Triple Negative Breast Neoplasms 55Glioblastoma 52Endometrial Neoplasms 51Lymphoma, Follicular 50Uterine Cervical Neoplasms 49Sarcoma 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lung Diseases, Interstitial × 90 days × Clear all
NCT07396467 2026-03-17

IPF-LC-IO

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting
200 enrolled
Thoracic

Disease, Lung Neoplasms, Pulmonary Fibrosis, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡